Drug news—March/April 2023A review of new launches, new indications, new dosage forms and Health Canada advisories. Health minister says stiffer rules could prevent over prescribing to U.S. patientsConcern over potential drug shortages arose after a Texas-based doctor licensed in Nova Scotia wrote 17,000 prescriptions for Ozempic over three months, but for people living in the United States. Ryaltris will soon be available for treating seasonal allergic rhinitis symptoms Intranasal spray contains an antihistamine and a corticosteroid for twice-daily use in persons six years of age or older. Unproven premature birth drug Makena forced off market by U.S. FDA The decision follows repeated efforts by Swiss drugmaker Covis Pharma to keep Makena on the U.S. market while it conducted additional studies. The buzz on natural health products Key drug interactions, safety issues, and how to approach NHP use by your patients. Full list of contraceptives now free to patients through new B.C. initiative The province provided key information for prescribers and pharmacists adapting to the new coverage options. A different kind of 'morning after pill': An antibiotic to prevent certain STIs? Single dose of doxycycline could prevent certain infections if taken within hours of unprotected sex. First treatment for generalized pustular psoriasis in adults approved Health Canada has approved Spevigo, the first treatment for flares in adults who have generalized pustular psoriasis. What is xylazine? A medical toxicologist explains how it increases overdose risk, and why Narcan can still save a life Xylazine is increasingly appearing within the U.S. supply of illicit opioids like fentanyl and heroin. U.S. FDA approves over the counter Narcan. Here's what it means It’s a move that some advocates have long sought as a way to improve access to a life-saving drug, though the exact impact will not be clear immediately. First Previous 50 51 52 53 54 Next Last
